Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New treatments for Chlamydia trachomatis.

R B Jones1

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis.

American Journal of Obstetrics and Gynecology
|June 1, 1991
PubMed
Summary

Standard antibiotics like doxycycline are effective for Chlamydia trachomatis, but persistence and resistance need study. Azithromycin offers a promising single-dose option for uncomplicated infections, improving compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-Life Air Pollution Exposure Is Associated with the Infant Gut Microbiome and Fecal Metabolome in the First Two Years of Life.

Research report (Health Effects Institute)·2026
Same author

HIV-1 Integration Site Determines the Transcriptional Fate and Persistence of Integrated Proviruses.

bioRxiv : the preprint server for biology·2026
Same author

PRISM-Seq: An Ultra-sensitive Sequencing Approach For Mapping Lentiviral Integration Sites.

bioRxiv : the preprint server for biology·2026
Same author

Facial recognition lock technology for social care settings: A qualitative evaluation of implementation of facial recognition locks at two residential care sites.

Frontiers in digital health·2023
Same author

Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA.

Journal of virus eradication·2023
Same author

Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.

Pediatric obesity·2018

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Chlamydia trachomatis is a common bacterial cause of sexually transmitted infections.
  • Standard antibiotic treatments including tetracycline, doxycycline, and erythromycin are generally effective.
  • Treatment failures can occur, with reasons including noncompliance and potential antibiotic resistance.

Purpose of the Study:

  • To evaluate the effectiveness of standard and newer antibiotics against Chlamydia trachomatis.
  • To investigate the potential for treatment failure and the role of compliance and resistance.
  • To assess azithromycin as a treatment option, particularly for uncomplicated urogenital infections.

Main Methods:

  • Review of existing data on antibiotic efficacy for Chlamydia trachomatis.
  • Analysis of factors contributing to treatment non-response.
  • Evaluation of azithromycin's effectiveness, including single-dose regimens.

Main Results:

  • Standard antibiotics (tetracycline, doxycycline, erythromycin) are effective in most cases.
  • Instances of persistent Chlamydia trachomatis infections despite therapy warrant further investigation.
  • Azithromycin shows promise for uncomplicated urogenital C. trachomatis infections.
  • Single-dose azithromycin may improve patient compliance.

Conclusions:

  • While standard antibiotics are largely effective, persistent infections and resistance require further research.
  • Azithromycin is a viable and potentially advantageous option for treating uncomplicated C. trachomatis infections.
  • Single-dose azithromycin therapy can enhance compliance, a critical factor in STD treatment.

Related Experiment Videos